Royal Blackburn Hospital: 'My dad, 80, spent 36 hours on corridor trolley'
Gail Myerscough says she is “horrified” patients are put on trolleys in corridors at Royal Blackburn.
Similar Posts
Heart disease risk increases for young adults who have lost a sibling, study finds
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Gamers at risk of irreversible hearing loss and tinnitus, study suggests
A new review of available evidence suggests video gamers regularly exceed safe sound limits.
Bowels, bladders and sex: Rediscovering life after mountain crash
Extreme sportsman Niall McCann talks frankly about life after crashing into a mountain at 50mph.
Humana reports grim 2024 forecast due to soaring medical costs
Signage is displayed on a Humana Inc. office building in Louisville, Kentucky, U.S., on Sunday, Feb. 3, 2019. Humana is scheduled to release earnings figures on February 6. Photographer: Luke Sharrett/Bloomberg via Getty Images Bloomberg | Bloomberg | Getty Images Shares of Humana plummeted on Thursday after the health insurer issued dismal full-year earnings guidance,…
Ozempic and Wegovy overdose calls have spiked, experts say — what to know about dangerous doses
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Pharma had a year full of firsts
Soumyabrata Roy | Nurphoto | Getty Images Drugmakers are closing out a year when they achieved several historic firsts that will shape the pharmaceutical industry in 2024 and beyond. The weight loss drug market transformed into the pharmaceutical industry’s newest gold rush this year, as demand for costly but highly effective treatments from Novo Nordisk…